| Quarterly Financials | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
Revenue  | 0 | 682 | 1,145 | 1,224 | 1,292 | 1,285 | 1,170 | 1,306 | 1,160 | 1,139 | 1,077 | 1,020 | 969 | 1,070 | 1,020 | 1,040 | 1,056 | 1,047 | 1,041 | 1,121 |
| Expenses | 0 | 580 | 863 | 1,027 | 1,074 | 1,153 | 1,025 | 1,151 | 1,007 | 1,043 | 959 | 902 | 871 | 983 | 915 | 921 | 919 | 905 | 896 | 985 |
| EBITDA | 0 | 102 | 281 | 197 | 219 | 132 | 145 | 156 | 153 | 96 | 119 | 118 | 98 | 87 | 105 | 119 | 137 | 142 | 145 | 135 |
| Operating Profit % | 0 % | 15 % | 24 % | 16 % | 16 % | 10 % | 12 % | 11 % | 13 % | 8 % | 10 % | 11 % | 9 % | 7 % | 9 % | 11 % | 12 % | 13 % | 13 % | 11 % |
| Depreciation | 0 | 22 | 32 | 31 | 30 | 31 | 31 | 31 | 30 | 30 | 32 | 34 | 34 | 36 | 39 | 40 | 40 | 39 | 41 | 41 |
| Interest | 0 | 7 | 13 | 7 | 5 | 6 | 4 | 5 | 7 | 6 | 12 | 13 | 15 | 14 | 14 | 15 | 12 | 14 | 13 | 12 |
| Profit Before Tax | 0 | 77 | 243 | 165 | 187 | 115 | 116 | 124 | 122 | 76 | 81 | 80 | 55 | 51 | 66 | 80 | 96 | 102 | 100 | 93 |
| Tax | 0 | 23 | 75 | 54 | 58 | 46 | 36 | 40 | 30 | 23 | 24 | 22 | 17 | 22 | 17 | 21 | 26 | 28 | 25 | 23 |
| Net Profit | 0 | 54 | 168 | 111 | 129 | 69 | 79 | 84 | 92 | 52 | 58 | 58 | 39 | 29 | 49 | 59 | 69 | 74 | 75 | 70 |
| EPS in ₹ | 0.00 | 5.20 | 10.58 | 6.97 | 8.12 | 4.31 | 4.99 | 5.31 | 5.75 | 3.29 | 3.63 | 3.64 | 2.44 | 1.85 | 3.08 | 3.73 | 4.39 | 4.69 | 4.75 | 4.40 |
Jubilant Ingrevia
Jubilant Ingrevia
689.95
-7.55
(-1.08%)
Company has added their latest Transcript1 day ago
View
Key Fundamentals
Market Cap
10,989.60 Cr
EPS
15.89
PE Ratio
38.13
Dividend Yield
0.73 %
Industry
Chemicals 52 Week High
885.00
52 Week Low
535.20
PB Ratio
3.75
Debt to Equity
0.27
Sector
Specialty Chemicals Analyst Rating and Forecast
- By Refinitiv from3 analysts
Actual
Company News
View All News
Jubilant Ingrevia achieved its highest quarterly revenue in 10 quarters at INR 1,121 crore, representing 7% year-on-year growth driven by 18% volume expansion. The company reported 8% EBITDA growth to INR 146 crore and 18% increase in profit after tax to INR 70 crore. The Specialty Chemicals segment delivered 12% revenue growth with 26% EBITDA margins, while adding 10+ new molecules with INR 1,200 crore peak annual revenue potential. The company expanded its opportunity funnel to 100+ active opportunities worth INR 3,500 crore potential revenue. A major CDMO contract worth $300 million over 5 years is set to begin in early 2026. The Nutrition segment saw strong volume growth in vitamins B3 and B4, though pricing pressures affected margins. Chemical Intermediates achieved highest quarterly sales in 6 quarters. The company commissioned renewable power at Bharuch, bringing total renewable share to 28% of power requirements, resulting in 16% reduction in energy costs.
Jubilant Ingrevia Plans 18 New Product Launches in FY'26, Targets INR 2,000 Crore EBITDA by FY'30
4 days ago
4 days agoJubilant Ingrevia announced plans to introduce 18 new products in FY'26, with focus on growth areas including cosmetics and semiconductor chemicals. The company expects improved margins in its nutrition business as prices stabilize and the share of cosmetic and food-grade products increases. Jubilant Ingrevia has set a target of achieving INR 2,000 crore EBITDA by FY'30. The company anticipates continued growth in H2 FY'26, driven by specialty chemicals and nutritional sectors, along with expected partial recovery in acetyl products.
Jubilant Ingrevia has announced a revenue target of ₹7,500-8,000 crore and 20 percent EBITDA margin by FY27. The company plans to achieve this through a ₹2,000 crore capital expenditure in specialty chemicals, a CDMO pipeline with ₹1,200 crore peak sales potential, and expected growth in nutrition demand.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,444.60 | #1 1,47,019.00 | 65.47 | 13,387.50 | 6.91 | #1 2,096 | 8.20 | 34.51 | |
2,930.50 | 86,867.30 | 53.64 | 14,825.80 | 12.13 | 1,251 | 92.75 | 39.84 | |
3,743.60 | 41,123.40 | 66.08 | 4,853.20 | 10.61 | 546 | 70.37 | 55.58 | |
5,687.40 | 29,122.80 | 65.73 | 2,393.10 | 12.83 | 289 | #1 152.38 | 77.82 | |
1,728.40 | 23,574.20 | 38.84 | 8,365.80 | 7.84 | 697 | -44.54 | 33.03 | |
4,412.00 | 19,097.60 | 48.25 | #1 15,339.40 | 10.81 | 479 | -37.72 | 39.07 | |
1,652.30 | 17,128.70 | 40.25 | 2,292.50 | 18.24 | 405 | 23.75 | 38.61 | |
5,762.50 | 16,965.80 | #1 30.21 | 5,692.40 | #1 18.99 | 499 | 30.75 | 34.07 | |
379.95 | 13,776.80 | 58.10 | 7,285.40 | 14.16 | 331 | -68.61 | 49.37 | |
4,437.20 | 13,604.40 | 32.83 | 2,366.70 | 7.83 | 411 | 3.35 | 36.83 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
1.06 %
Net Income Growth
37.34 %
Cash Flow Change
18.17 %
ROE
28.44 %
ROCE
18.41 %
EBITDA Margin (Avg.)
20.75 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 0 | 3,379 | 3,797 | 4,259 | 4,732 | 5,032 |
| Fixed Assets | 0 | 1,805 | 1,798 | 1,846 | 2,539 | 2,581 |
| Current Assets | 0 | 1,424 | 1,765 | 1,818 | 1,780 | 1,853 |
| Capital Work in Progress | 0 | 65 | 174 | 525 | 331 | 525 |
| Investments | 0 | 50 | 6 | 8 | 16 | 37 |
| Other Assets | 0 | 1,458 | 1,819 | 1,880 | 1,846 | 1,889 |
| Total Liabilities | 0 | 3,379 | 3,797 | 4,259 | 4,732 | 5,032 |
| Current Liabilities | 0 | 894 | 1,053 | 1,180 | 1,286 | 1,401 |
| Non Current Liabilities | 0 | 561 | 311 | 413 | 708 | 704 |
| Total Equity | -0 | 1,923 | 2,433 | 2,666 | 2,738 | 2,927 |
| Reserve & Surplus | -0 | 1,907 | 2,417 | 2,650 | 2,722 | 2,911 |
| Share Capital | 0 | 16 | 16 | 16 | 16 | 16 |
Cash Flow
| Cash Flow | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 73 | -36 | 35 | 6 | -9 |
| Investing Activities | 0 | 33 | -71 | -469 | -568 | -389 |
| Operating Activities | 0 | 112 | 453 | 463 | 430 | 508 |
| Financing Activities | 0 | -72 | -418 | 42 | 144 | -129 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 50.68 % | 50.92 % | 50.92 % | 51.03 % | 51.10 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 51.47 % | 45.22 % | 45.22 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 6.35 % | 6.58 % | 6.55 % | 7.22 % | 6.89 % | 7.12 % | 6.96 % | 5.96 % |
| DIIs | 0.83 % | 0.96 % | 0.32 % | 0.14 % | 0.15 % | 0.17 % | 1.38 % | 4.90 % | 5.98 % | 6.73 % | 8.21 % | 11.18 % | 13.61 % | 14.09 % | 15.47 % | 15.99 % | 15.92 % | 21.80 % | 23.04 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.02 % |
| Public / Retail | 16.76 % | 21.30 % | 27.18 % | 26.23 % | 27.31 % | 27.61 % | 26.71 % | 25.75 % | 25.72 % | 26.13 % | 24.11 % | 22.74 % | 20.63 % | 20.57 % | 19.47 % | 19.17 % | 19.13 % | 19.41 % | 19.20 % |
| Others | 31.74 % | 26.82 % | 21.58 % | 22.60 % | 21.43 % | 20.75 % | 20.44 % | 17.87 % | 16.83 % | 15.66 % | 16.20 % | 8.26 % | 7.71 % | 7.32 % | 6.36 % | 6.47 % | 6.36 % | 6.60 % | 6.56 % |
| No of Share Holders | 60,038 | 95,235 | 1,49,939 | 1,81,847 | 1,91,477 | 1,93,858 | 1,95,704 | 1,86,895 | 1,85,062 | 1,86,294 | 1,73,533 | 1,62,202 | 1,50,388 | 1,42,736 | 1,25,367 | 1,24,830 | 1,20,406 | 1,23,748 | 1,25,749 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.35 | 5 | 5 | 5 | 5 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.08 | 1.39 | 1.1 | 0.77 | 0.72 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 01 Feb 2021 |  Change Of Name | NA | 01 Feb 2021 | 0.00 | 0.00 |
| 06 Aug 2021 |  Dividend | ₹ 0.35 /share | 05 Aug 2021 | 571.85 | 610.15 |
| 11 Feb 2022 | Dividend | ₹ 2.50 /share | 10 Feb 2022 | 572.25 | 567.85 |
| 24 Aug 2022 | Dividend | ₹ 2.50 /share | 23 Aug 2022 | 464.15 | 476.15 |
| 10 Feb 2023 | Dividend | ₹ 2.50 /share | 10 Feb 2023 | 472.90 | 472.65 |
| 10 Aug 2023 | Dividend | ₹ 2.50 /share | 10 Aug 2023 | 422.00 | 433.05 |
| 09 Feb 2024 | Dividend | ₹ 2.50 /share | 09 Feb 2024 | 460.65 | 436.55 |
| 02 Aug 2024 | Dividend | ₹ 2.50 /share | 02 Aug 2024 | 519.65 | 612.55 |
| 30 Aug 2024 |  Annual General Meeting | NA | 30 Aug 2024 | 610.10 | 642.85 |
| 22 Oct 2024 |  Quarterly Result Announcement | NA | 22 Oct 2024 | 732.20 | 731.40 |
| 28 Jan 2025 | Quarterly Result Announcement | NA | 28 Jan 2025 | 711.10 | 659.30 |
| 03 Feb 2025 | Dividend | ₹ 2.50 /share | 03 Feb 2025 | 659.30 | 697.65 |
| 13 May 2025 | Quarterly Result Announcement | NA | 13 May 2025 | 696.10 | 718.00 |
| 25 Jul 2025 | Dividend | ₹ 2.50 /share | 25 Jul 2025 | 718.00 | 819.20 |
| 31 Jul 2025 | Quarterly Result Announcement | NA | 31 Jul 2025 | 818.85 | 810.60 |
| 29 Aug 2025 | Annual General Meeting | NA | 29 Aug 2025 | 754.40 | 727.55 |
| 27 Oct 2025 | Quarterly Result Announcement | NA | 27 Oct 2025 | 650.85 | 677.70 |
Announcements
Announcement under Regulation 30 (LODR)-Earnings Call Transcript1 day ago
1 day agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication4 days ago
4 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Press Release / Media Release5 days ago
5 days agoGrant Of Options/ Restricted Stock Units (Rsus) Under Jubilant Ingrevia Employees Stock Option Plan 20215 days ago
5 days agoUnaudited Financial Results For Quarter And Half Year Ended 30 September 20255 days ago
5 days agoUnaudited Financial Results For Quarter And Half Year Ended 30 September 20255 days ago
5 days agoBoard Meeting Outcome for Meeting Held On October 27 20255 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 13, 2025
Oct 13, 2025Board Meeting Intimation for Adoption Of Unaudited Half Yearly Results As On September 30 2025Oct 13, 2025
Oct 13, 2025Commercial Paper Proceeds Utilisation Certificate For The Quarter Ended September 30 2025Oct 10, 2025
Oct 10, 2025Submission Of Communication Email Sent To Shareholders Whose Dividend(S) Remains Unpaid Pursuant To "Saksham Niveshak - 100 Days Campaign"Oct 10, 2025
Oct 10, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Oct 08, 2025Closure of Trading WindowOct 01, 2025
Oct 01, 2025Certificate Under Chapter XVII Of SEBI Operational Circular Dated 22Nd May 2024 As AmendedSep 25, 2025
Sep 25, 2025Intimation of Repayment of Commercial Paper (CP)Sep 25, 2025
Sep 25, 2025Intimation Of Record Date For Maturity Of Commercial PaperSep 25, 2025
Sep 25, 2025Announcement under Regulation 30 (LODR)-Issue of SecuritiesSep 25, 2025
Sep 25, 2025Announcement under Regulation 30 (LODR)-Issue of SecuritiesSep 22, 2025
Sep 22, 2025Intimation Of Record Date For Maturity Of Commercial PaperSep 22, 2025
Sep 22, 2025Intimation of Repayment of Commercial Paper (CP)Sep 16, 2025
Sep 16, 2025Certificate Under Chapter XVII Of SEBI Operational Circular Dated 22Nd May 2024 As AmendedSep 16, 2025
Sep 16, 2025Intimation of Repayment of Commercial Paper (CP)Sep 15, 2025
Sep 15, 2025Certificate Under Chapter XVII Of SEBI Operational Circular Dated 22Nd May 2024 As AmendedSep 15, 2025
Sep 15, 2025Appointment And Re-Appointment Of Directors Statutory Auditors And Secretarial AuditorsAug 29, 2025
Aug 29, 2025Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sAug 29, 2025
Aug 29, 2025Appointment And Re-Appointment Of Directors Statutory Auditors And Secretarial AuditorsAug 29, 2025
Aug 29, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 29, 2025
Aug 29, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMAug 29, 2025
Aug 29, 2025Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Aug 19, 2025
Aug 19, 2025Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Aug 19, 2025
Aug 19, 2025Intimation Of Record Date For Maturity Of Commercial PapersAug 13, 2025
Aug 13, 2025Announcement under Regulation 30 (LODR)-Credit RatingAug 13, 2025
Aug 13, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 13, 2025
Aug 13, 2025Announcement under Regulation 30 (LODR)-Issue of SecuritiesAug 11, 2025
Aug 11, 2025E-Mail To Shareholders Intimating About Deduction Of Tax At Source (TDS) On Final Dividend For FY 2024-25Aug 07, 2025
Aug 07, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Transcript Of The Investors Conference
Call For The Quarter Ended June 30 2025Aug 06, 2025
Aug 06, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 06, 2025
Aug 06, 2025Intimation Regarding Letter Dispatched To The Shareholders Of The Company For Annual Report Of The Company For FY 2024-25Aug 06, 2025
Aug 06, 2025Notice Of 6Th Annual General Meeting Along With Annual Report For The Financial Year 2024-25Aug 05, 2025
Aug 05, 2025Reg. 34 (1) Annual Report.Aug 05, 2025
Aug 05, 2025Notice Of 6Th Annual General Meeting Along With The Annual Report For The Financial Year 2024-25Aug 05, 2025
Aug 05, 2025Business Responsibility and Sustainability Reporting (BRSR)Aug 05, 2025
Aug 05, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 03, 2025
Aug 03, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 02, 2025
Aug 02, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 01, 2025
Aug 01, 2025Audio Recording Of Investors Conference CallJul 31, 2025
Jul 31, 2025Redemption Of Commercial PapersJul 31, 2025
Jul 31, 2025Certificate Under Chapter XVII Of SEBI Operational Circular Dated 22Nd May 2024 As AmendedJul 31, 2025
Jul 31, 2025Mutual Fund Holdings
Bandhan Small Cap Fund Direct-Growth 
HDFC Manufacturing Fund Direct - Growth 
Kotak Small Cap Fund Direct-Growth 
UTI Small Cap Fund Direct - Growth 
Nippon India Nifty Smallcap 250 Index Fund Direct - Growth 
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth 
SBI Nifty Smallcap 250 Index Fund Direct - Growth 
Motilal Oswal Nifty Smallcap 250 Index Fund Direct - Growth 
ICICI Prudential Nifty Smallcap 250 Index Fund Direct - Growth 
JioBlackRock Nifty Smallcap 250 Index Fund Direct - Growth 
Edelweiss Nifty Smallcap 250 Index Fund Direct - Growth 
Groww Nifty Smallcap 250 Index Fund Direct - Growth Technical Indicators
RSI(14)
Neutral 51.34
ATR(14)
Less Volatile 22.46
STOCH(9,6)
Neutral 47.84
STOCH RSI(14)
Neutral 57.02
MACD(12,26)
Bullish 2.35
ADX(14)
Weak Trend 19.09
UO(9)
Bearish 55.73
ROC(12)
Downtrend And Accelerating -3.21
WillR(14)
Neutral -45.53
About Jubilant Ingrevia
Jubilant Ingrevia Limited is a global integrated Life Science products and Innovative Solutions provider. Incorporated in 2019, the company serves Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers. It operates through three core segments: Speciality Chemicals, Nutrition and Health Solutions, and Life Science Chemicals. The company manufactures and supplies speciality intermediates, nutrition & health solutions, and life science chemicals through five facilities in India. Jubilant Ingrevia is the global largest producer of Niacinamide and among the top two manufacturers of Vitamin B3 globally. It serves over 1400 customers in more than 60 countries and offers custom research and manufacturing services. The company is part of the Jubilant Bhartia Group and became a separate entity following a demerger from Jubilant Pharmova Limited in 2021.
Chairperson NameShyam S Bhartia
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
